Los Angeles Capital Management LLC grew its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 148.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,068 shares of the health services provider’s stock after acquiring an additional 9,590 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Maximus were worth $1,377,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in Maximus by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after purchasing an additional 145,983 shares during the period. Janus Henderson Group PLC grew its holdings in Maximus by 2.1% in the 1st quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider’s stock worth $105,255,000 after buying an additional 25,825 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Maximus by 8.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,062,173 shares of the health services provider’s stock valued at $89,075,000 after acquiring an additional 79,729 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Maximus by 1.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 716,501 shares of the health services provider’s stock valued at $60,086,000 after acquiring an additional 8,702 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its position in Maximus by 0.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 705,302 shares of the health services provider’s stock worth $59,175,000 after acquiring an additional 3,680 shares during the period. Institutional investors own 97.21% of the company’s stock.
Maximus Trading Down 0.5 %
NYSE:MMS opened at $85.91 on Thursday. Maximus, Inc. has a 1 year low of $72.39 and a 1 year high of $93.97. The business has a fifty day moving average of $89.38 and a 200-day moving average of $85.92. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. The stock has a market cap of $5.22 billion, a price-to-earnings ratio of 22.55 and a beta of 0.76.
Maximus Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.40%. Maximus’s dividend payout ratio (DPR) is 31.50%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories
- Five stocks we like better than Maximus
- What is Insider Trading? What You Can Learn from Insider Trading
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- What is Short Interest? How to Use It
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Conference Calls and Individual Investors
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.